Clinical Trial

the Aorta Arch Stent Graft System Combined With the Endovascular Needle System in Situ Fenestration

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A prospective, multi-center, single-group target value method to evaluate the safety and effectiveness of the Aorta Arch Stent Graft System combined with the Endovascular Needle System in situ fenestration technology in the treatment of aortic dissection involving the aortic arch
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-11-08; most recent amendment 2024-07-21.
Status change: Recruiting → Active, Not Recruiting 2024-07-21
Trial Details
NCT Number NCT05126446
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions Aortic Dissection
Enrollment 120 participants
Start Date 2021-07-25
Primary Completion 2027-10-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2024-07-23